CM
TEVA icon

Caption Management’s Teva Pharmaceuticals TEVA Stock Holding History

Caption Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.75M Sell
258,331
-21,727
-8% -$724K 0.04% 432
2026
Q1 		$8.44M Buy
280,058
+215,058
+331% +$6.92M 0.05% 376
2025
Q4 		$2.03M Buy
+65,000
New +$1.6M 0.01% 829
2025
Q2 		– Sell
-259,800
Closed -$3.99M – 1886
2025
Q1 		$3.99M Buy
259,800
+213,664
+463% +$3.82M 0.04% 470
2024
Q4 		$1.02M Sell
46,136
-138,164
-75% -$2.51M 0.01% 908
2024
Q3 		$3.32M Buy
184,300
+141,700
+333% +$2.48M 0.05% 413
2024
Q2 		$692K Buy
+42,600
New +$656K 0.01% 747
2023
Q4 		– Sell
-369,461
Closed -$3.77M – 1670
2023
Q3 		$3.77M Buy
369,461
+13,471
+4% +$125K 0.06% 395
2023
Q2 		$2.68M Buy
+355,990
New +$2.89M 0.05% 429
2023
Q1 		– Sell
-410,000
Closed -$3.74M – 1543
2022
Q4 		$3.74M Sell
410,000
-472,115
-54% -$4.12M 0.06% 390
2022
Q3 		$7.12M Buy
882,115
+51,627
+6% +$457K 0.1% 248
2022
Q2 		$6.25M Buy
830,488
+243,500
+41% +$2.12M 0.09% 286
2022
Q1 		$5.51M Sell
586,988
-213,012
-27% -$1.78M 0.07% 386
2021
Q4 		$6.41M Buy
+800,000
New +$7.22M 0.07% 379
2021
Q2 		– Sell
-6,000
Closed -$63.5K – 1562
2021
Q1 		$69K Buy
+6,000
New +$68.8K ﹤0.01% 973
2019
Q1 		– Sell
-261,602
Closed -$4.61M – 721
2018
Q4 		$4.03M Buy
+261,602
New +$5.36M 0.32% 100

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Caption Management's TEVA Position: Q2 2026 in Review

Caption Management reduced its Teva Pharmaceuticals (TEVA) stake by 7.8% in Q2 2026, selling an estimated $724K and leaving 258,331 shares worth $8.75M. The position accounts for 0.04% of the portfolio, ranked #432.

Caption Management first reported a position in TEVA in Q4 2018 and has held it in 16 quarters since. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Caption Management held 258,331 shares of Teva Pharmaceuticals worth $8.75M as of Q2 2026.
  • Caption Management sold 21,727 Teva Pharmaceuticals shares in Q2 2026, an estimated $724K.
  • Teva Pharmaceuticals made up 0.04% of Caption Management's portfolio in Q2 2026, its #432 holding.
  • Caption Management first reported a position in Teva Pharmaceuticals in Q4 2018 and has held it in 16 quarters since.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Caption Management's 13F filing for Q2 2026, filed 14 Aug 2026.